Literature DB >> 35401840

Erratum: Myocardium-targeted transplantation of PHD2 shRNA-modified bone mesenchymal stem cells through ultrasound-targeted microbubble destruction protects the heart from acute myocardial infarction: Erratum.

Zhenxing Sun1,2, Yuji Xie1,2, Robert J Lee3, Yihan Chen1,2, Qiaofeng Jin1,2, Qing Lv1,2, Jing Wang1,2, Yali Yang1,2, Yuman Li1,2, Yu Cai1,2, Rui Wang1,2, Zhengyang Han1,2, Li Zhang1,2, Mingxing Xie1,2.   

Abstract

[This corrects the article DOI: 10.7150/thno.43233.]. © The author(s).

Entities:  

Year:  2022        PMID： 35401840      PMCID： PMC8965490          DOI： 10.7150/thno.72333

Source DB:  PubMed          Journal:  Theranostics        ISSN： 1838-7640            Impact factor:   11.556


The authors apologize that the original version of this paper unfortunately contained two incorrect figures and a terminology error due to negligence in drafting and proofreading. Firstly, in Section A of Figure 2, the DAPI and Merge images of the control group were not presented correctly. Secondly, Section B and Section C of Figure 7 were reversely marked. In addition, the term MI-LV-shPHD2-BMSC in the last paragraph of the Results section should be “MI-LV-GFP-BMSC” (Page 4977). The authors apologize for any inconvenience these errors may have caused. Luckily they have no influence on the conclusion drawn by the study. The correct figures are shown below.
  1 in total

1.  Myocardium-targeted transplantation of PHD2 shRNA-modified bone mesenchymal stem cells through ultrasound-targeted microbubble destruction protects the heart from acute myocardial infarction.

Authors:  Zhenxing Sun; Yuji Xie; Robert J Lee; Yihan Chen; Qiaofeng Jin; Qing Lv; Jing Wang; Yali Yang; Yuman Li; Yu Cai; Rui Wang; Zhengyang Han; Li Zhang; Mingxing Xie
Journal:  Theranostics       Date:  2020-04-06       Impact factor: 11.556
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.